US Bancorp’s Aceragen Inc ACGN Stock Holding History

US Bancorp’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-36	Closed	-$9K	–	3718
2018 Q1	$9K	Sell	36 -4	-10%	-$1.1K	﹤0.01%	3192
2017 Q4	$11K	Buy	+40	New	+$11.4K	﹤0.01%	3112

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp's ACGN Position: Q2 2018 in Review

US Bancorp sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 36 shares — an estimated $9K sold.

US Bancorp first reported a position in ACGN in Q4 2017 and held it in 2 quarters. The position peaked at $11K in Q4 2017. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

US Bancorp reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
US Bancorp sold 36 Aceragen Inc shares in Q2 2018, an estimated $9K.
US Bancorp first reported a position in Aceragen Inc in Q4 2017 and held it in 2 quarters.
US Bancorp's Aceragen Inc position peaked at $11K in Q4 2017.
93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on US Bancorp's 13F filing for Q2 2018, filed 8 Aug 2018.